Athens, GA, United States of America

Donald Martin Carter, Jr

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Oregon Health & Science University, Sanofi Pasteur Inc., University of Pittsburgh. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Martin Carter, Jr. Retrieved from https://idiyas.com/inventor/donald-martin-carter-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 57.1

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Port St. Lucie, FL (US) (2016)
  • Athens, GA (US) (2017 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Donald Martin Carter, Jr.

Introduction

Donald Martin Carter, Jr. is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of immunology, particularly in the development of innovative approaches to combat influenza viruses. With a total of 7 patents, his work focuses on enhancing protective immunity against various strains of influenza.

Latest Patents

Carter's latest patents include groundbreaking inventions such as the "Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza." This invention provides a method for the co-administration of optimized H1N1 influenza hemagglutinin (HA) polypeptides, facilitating synergistic neutralization of viral infections. It aims to improve protective immunity against diverse H1N1 influenza virus strains, including both seasonal and pandemic variants. Another significant patent is the "Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian H5N1 influenza." This invention also focuses on co-administration of optimized H5N1 influenza hemagglutinin (HA) polypeptides, enhancing immunity against multiple H5N1 influenza virus clades and strains.

Career Highlights

Throughout his career, Carter has worked with esteemed institutions such as Oregon Health & Science University and the University of Pittsburgh. His research has contributed to advancements in vaccine development and immunological responses to influenza viruses.

Collaborations

Carter has collaborated with notable colleagues, including Ted Milburn Ross and Ted M Ross, further enhancing the impact of his research in the field of immunology.

Conclusion

Donald Martin Carter, Jr. is a distinguished inventor whose work in influenza research has led to significant advancements in vaccine development. His innovative patents reflect his commitment to improving public health through enhanced immunological strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…